Recent results concerning molecular molybdenum sulfido clusters as model systems for heterogeneous hydrogen evolution catalysis by molybdenum sulfides are summarized and also compared to the related chemistry of the active site of the enzyme Mo-nitrogenase.
Amorphous
molybdenum sulfide (MoS
x
)
is a potent catalyst for the hydrogen evolution reaction (HER). Since
mechanistic investigations on amorphous solids are particularly difficult,
we use a bottom-up approach and study the [Mo
3
S
13
]
2–
nanocluster and its protonated forms. The mass
selected pure [Mo
3
S
13
]
2–
as
well as singly and triply protonated [HMo
3
S
13
]
−
and [H
3
Mo
3
S
13
]
+
ions, respectively, were investigated by a combination
of collision induced dissociation (CID) experiments and quantum chemical
calculations. A rich variety of H
x
S
y
elimination channels was observed, giving
insight into the structural flexibility of the clusters. In particular,
it was calculated that the observed clusters tend to keep the Mo
3
ring structure found in the bulk and that protons adsorb
primarily on terminal disulfide units of the cluster. Mo–H
bonds are formed only for quasi-linear species with Mo centers featuring
empty coordination sites. Protonation leads to increased cluster stability
against CID. The rich variety of CID dissociation products for the
triply protonated [H
3
Mo
3
S
13
]
+
ion, however, suggests that it has a large degree of structural
flexibility, with roaming H/SH moieties, which could be a key feature
of MoS
x
to facilitate HER catalysis via
a Volmer−Heyrovsky mechanism.
Materials based on molybdenum sulfide are known as efficient hydrogen evolution reaction (HER) catalysts. As the binding site for H atoms on molybdenum sulfides for the catalytic process is under debate, [HMo 3 S 13 ] À is an interesting molecular model system to address this question. Herein, we probe the [HMo 3 S 13 ] À cluster in the gas phase by coupling Fourier-transform ion-cyclotron-resonance mass spectrometry (FT-ICR MS) with infrared multiple photon dissociation (IRMPD) spectroscopy. Our investigations show one distinct S À H stretching vibration at 2450 cm À1. Thermochemical arguments based on DFT calculations strongly suggest a terminal disulfide unit as the H adsorption site.
Molybdenum sulfides (MoSx, x > 2) are promising catalysts for the hydrogen evolution reaction (HER) that show high hydrogen evolution rates and potentially represent an abundant alternative to platinum. However, a complete understanding of the structure of the most active variants is still lacking. Nanocrystalline MoS2+δ was prepared by a solvothermal method and immobilized on graphene. The obtained electrodes exhibit stable HER current densities of 3 mA cm−2 at an overpotential of ~200 mV for at least 7 h. A structural analysis of the material by high-resolution transmission electron microscopy (HRTEM) show partially disordered nanocrystals of a size between 5–10 nm. Both X-ray and electron diffraction reveal large fluctuations in lattice spacing, where the average c-axis stacking is increased and the in-plane lattice parameter is locally reduced in comparison to the layered structure of crystalline MoS2. A three-dimensional structural model of MoS2+δ could be derived from the experiments, in which [Mo2S12]2− and [Mo3S13]2− clusters as well as disclinations represent the typical defects in the ideal MoS2 structure. It is suggested that the partially disordered nanostructure leads to a high density of coordinatively modified Mo sites with lower Mo–Mo distances representing the active sites for HER catalysis, and, that these structural features are more important than the S:Mo ratio for the activity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.